Class of Stock [Axis]
Common Stock, par value $0.0001 per share
Warrants, exercisable for one share of common stock
Equity Components [Axis]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Product and Service [Axis]
Clinical Operations [Member]
Drug Manufacturing And Formulation [Member]
Personnel [Member]
Regulatory [Member]
Legal and Professional Fees [Member]
Occupancy [Member]
Insurance [Member]
Other [Member]
Long-Lived Tangible Asset [Axis]
Equipment [Member]
Statistical Measurement [Axis]
Minimum [Member]
Maximum [Member]
Furniture and Fixtures [Member]
Computer Equipment [Member]
Leasehold Improvements [Member]
Construction In Progress Equipment [Member]
Legal Entity [Axis]
Werth Family Investment Associates LLC [Member]
Streetville Capital LLC [Member]
Scenario [Axis]
Forecast [Member]
Sale of Stock [Axis]
Private Placement [Member]
Class of Warrant or Right [Axis]
Series A and Series B Warrants [Member]
Pre Funded Warrants [Member]
WFIA Pre Funded Warrants [Member]
June 2024 Warrant Inducement [Member]
February 2024 Warrants [Member]
Common Class C [Member]
Series D Common Stock [Member
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Purchase Agreement [Member]
ATM Agreement [Member]
H.C. Wain Wright and Co LLC [Member]
Series A Warrants [Member]
Series B Warrants [Member]
Warrant [Member]
IPO [Member]
Over-Allotment Option [Member]
Series A Warrant [Member]
Series B Warrant [Member]
Placement Agent Warrants [Member]
Measurement Input Type [Axis]
Measurement Input, Risk Free Interest Rate [Member]
Measurement Input, Price Volatility [Member]
Series C And Series D Warrants [Member]
September Two Thousand Twenty Three Public Offering [Member]
Series A, B Placement Agent Warrants [Member]
February Two Thousand Twenty Four Public Offering [Member]
December 2021 Initial Public Offering Warrants [Member]
December 2021 Underwriter Warrants [Member]
September 2023 Public Offering Series A Warrants [Member]
September 2023 Public Offering Series B Warrants [Member]
September 2023 Placement Agent Warrants [Member]
February 2024 Public Offering Series A Warrants [Member]
February 2024 Public Offering Series B Warrants [Member]
February 2024 Placement Agent Warrants [Member]
June 2024- Series C Warrants [Member]
June 2024- Series D Warrants [Member]
July 2024 Placement Agent Warrants [Member]
Plan Name [Axis]
2021 Equity Incentive Plan [Member]
2021 [Equity Incentive Plan Plan Member]
Award Type [Axis]
Share-Based Payment Arrangement, Option [Member]
Title and Position [Axis]
Employees And Directors [Member]
Lease Contractual Term [Axis]
Kansas City Office [Member]
Office Facilities Space [Member]
Operating Lease [Member]
Antidilutive Securities [Axis]
Indefinite-Lived Intangible Assets [Axis]
Licensing Agreements [Member]
Vesting [Axis]
Phase 3 Clinical Trial [Member]
New Drug Application [Member]
CTx-1301 and CTx-1302 [Member]
CTx-2103 [Member]
CTx-2103 [Member]
Related and Nonrelated Parties [Axis]
Related Party [Member]
Financial Instrument [Axis]
Debt [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Lincoln Park Purchase Agreement [Member]
Statement [Table]
Statement [Line Items]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference
ICFR Auditor Attestation Flag
Document Financial Statement Error Correction [Flag]
Entity Listing, Par Value Per Share
Auditor Firm ID
Auditor Name
Auditor Location
Statement of Financial Position [Abstract]
ASSETS
Current assets:
Cash and cash equivalents
Miscellaneous receivables
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Operating lease right-of-use assets
Total assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
Accrued expenses
Notes payable, current
Finance lease liability, current
Operating lease liability, current
Total current liabilities
Long-term liabilities:
Note payable
Finance lease liability, net of current
Operating lease liability, net of current
Total long-term liabilities
Total liabilities
Stockholders’ Equity
Common Stock, $0.0001 par value; 240,000,000 shares authorized and 3,402,306 and 97,293 shares issued and outstanding as of December 31, 2024 and 2023
Preferred Stock, $0.0001 par value; 10,000,000 shares authorized and 0 shares issued and outstanding as of December 31, 2024 and 2023
Additional Paid-in-Capital
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Preferred stock, par value
Preferred stock, shares authorized
Preferred stock, shares issued
Preferred stock, shares outstanding
Income Statement [Abstract]
Operating expenses:
Research and development
General and administrative
Operating loss
Interest and other income (expense), net
Loss before income taxes
Income tax benefit (expense)
Net loss and comprehensive loss
Net loss per share of common stock, basic
Net loss per share of common stock, diluted
Weighted average number of shares used in computing net loss per share of common stock, basic
Weighted average number of shares used in computing net loss per share of common stock, diluted
Balance
Balance, shares
Issuance of common stock in connection with At the Market Offering and Purchase Agreement, net of fees
Issuance of common stock in connection with At the Market Offering and Purchase Agreement, net of fees, shares
Issuance of common stock in connection with private placement with WFIA
Issuance of common stock in connection with private placement with WFIA, shares
Issuance of common stock and pre-funded warrants sold for cash in public offering, net of fees
Issuance of common stock and pre-funded warrants sold for cash in public offering, net of fees, shares
Issuance of pre-funded warrants in connection with the conversion of related party note payable
Capital contribution in connection with conversion of related party note payable
Issuance of restricted common stock
Issuance of restricted common stock, shares
Stock-based compensation expense
Net loss
Share adjustment due to fractional rounding of August 2024 reverse split
Share adjustment due to fractional rounding of August 2024 reverse split, shares
Warrant inducement
Warrant inducement, shares
Issuance of common stock in public offering, net of fees
Issuance of common stock in public offering, net of fees, shares
Issuance of common stock upon exercise of pre-funded warrants
Issuance of common stock upon exercise of pre-funded warrants, shares
Balance
Balance, shares
Statement of Cash Flows [Abstract]
Operating activities:
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
Stock-based compensation
Changes in operating assets and liabilities:
Miscellaneous receivables
Prepaid expenses and other current assets
Operating lease right-of-use assets
Trade accounts payable and accrued expenses
Current portion of operating lease liability
Long-term portion of operating lease liability
Net cash used in operating activities
Investing activities:
Purchase of property and equipment
Net cash used in investing activities
Financing Activities:
Proceeds from the issuance of common stock and pre-funded common stock purchase warrants, net of fees
Proceeds from notes payable
Principal payments on finance lease obligations
Net cash provided by financing activities
Cash and cash equivalents:
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year
Non-cash activities
Property and equipment accrued but not paid at end of year
Cash payments:
Interest paid
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss)
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Awards Close in Time to MNPI Disclosures [Table]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Insider Trading Arrangements [Line Items]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Cybersecurity Risk Management, Strategy, and Governance [Abstract]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
Cybersecurity Risk Management Processes Integrated [Flag]
Cybersecurity Risk Management Processes Integrated [Text Block]
Cybersecurity Risk Management Third Party Engaged [Flag]
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]
Cybersecurity Risk Board of Directors Oversight [Text Block]
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]
Cybersecurity Risk Role of Management [Text Block]
Cybersecurity Risk Management Positions or Committees Responsible [Flag]
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]
Material Cybersecurity Incident [Abstract]
Material Cybersecurity Incident Nature [Text Block]
Material Cybersecurity Incident Scope [Text Block]
Material Cybersecurity Incident Timing [Text Block]
Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]
Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]
Accounting Policies [Abstract]
Nature of the Business and Liquidity
Summary of Significant Accounting Policies
Prepaid Expenses And Other Current Assets
Prepaid Expenses and Other Current Assets
Property, Plant and Equipment [Abstract]
Property and Equipment, net
Payables and Accruals [Abstract]
Accrued Expenses
Commitments and Contingencies Disclosure [Abstract]
Contingencies
Related Party Notes Payable
Related Party Notes Payable
Debt Disclosure [Abstract]
Unsecured Promissory Note
Equity [Abstract]
Stockholders’ Equity
Securities Issuances
Securities Issuances
Common Stock Purchase Warrants
Common Stock Purchase Warrants
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation
Income Tax Disclosure [Abstract]
Income Taxes
Leases
Leases
Earnings Per Share [Abstract]
Net Loss Per Share
Organization, Consolidation and Presentation of Financial Statements [Abstract]
License Agreement
Related Party Transactions [Abstract]
Related Party Transactions
Subsequent Events [Abstract]
Subsequent Events
Basis of Presentation and Principles of Consolidation
Use of Estimates
Concentration of Credit Risk
Recent Accounting Pronouncements
Cash and Cash Equivalents
Property and Equipment, net
Leases
Impairment of Long-lived Assets
Research and Development
Stock-Based Compensation
Segments
Income Taxes
Common Stock Purchase Warrants
Net Loss per Share
Schedule of operating results of company’s segment
Schedule of Prepaid Expenses and Other Current Assets
Schedule of Property and Equipment
Schedule of Accrued Expenses
Schedule of Interest Expense (Income)
Schedule of Fair Value of the Warrants to Additional Paid in Capital
Schedule of Warrants and Rights Outstanding
Summary of Option Activity
Schedule of Fair Value Assumption
Schedule of Effective Income Tax Rate Reconciliation
Schedule of Deferred Tax Assets and Liabilities
Summary of Components of Lease Cost
Summary of Lease Reported in Consolidated Balance Sheets
Summary of Other Information Relating to Leases
Summary of Maturity of Lease Liabilities
Schedule of Net Loss Per Share Basic and Diluted
Schedule of Potentially Dilutive Securities
Accumulated deficit
Nature of Operation, Product Information, Concentration of Risk [Table]
Product Information [Line Items]
Research and development
Total research and development
Total general and administrative
Federal deposit insurance corporation limit
Schedule Of Prepaid Expenses And Other Current Assets
Research and development
Other
Active pharmaceutical ingredients
Dues and subscriptions
Deferred capital raise costs
Insurance
Total prepaid expenses and other current assets
Property, Plant and Equipment [Table]
Property, Plant and Equipment [Line Items]
Property and equipment, gross
Property and equipment, estimated useful life
Less: accumulated depreciation
Property and equipment, net
Depreciation expense
Employee compensation
Research and development
State franchise taxes
Other
Insurance
CIP- Equipment
Interest
Professional fees
Total accrued expenses
Unpaid salary
Issuance of debt
Unsecured interest percentage
Issuance of long term debt
Debt face amount
Issuance date fair value total
Number of warrants
Issuance date fair value per warrant
Exercise price
Debt instrument, description
Warrants, excercise price
Interest expense - other
Interest income
Total
Unsecured promissory note amount
Unsecured promissory note original discount
Lender expenses on issue of debt
Proceeds from issuance of promissory note
Interest rate percent
Redemption of promissory note
Description of monitoring fee in event of default
Description of monitoring fee in event of default
Debt issuance costs
Unsecured promissory note discount
Long-term debt outstanding including accrued interest
Common stock shares authorized
Common stock par value
Preferred stock shares authorized
Preferred stock par value
Stockholders equity, reverse stock split
Number of shares issued, shares
Share price
Gross proceeds
Prefunded warrants
Warrant exercise price
Debt descripition
Gross proceeds
Placement agent fees
Existing warrants to purchase
Proceeds from Issuance Initial Public Offering
Payments of stock issuance costs
Proceeds from issuance or sale of equity
Proceeds from issuance of common stock
Sale of stock
Number of shares issued
Sale of stock, shares
Sale of stock commission percent
Increase in aggregate value
Fair value
Percent of Total Fair Value
Amount Allocated
Class of Warrant or Right [Table]
Class of Warrant or Right [Line Items]
Issuance Date Fair Value Per Warrant
Issuance Date Fair Value Total
Prefunded warrants
Warrants, exercise price
Warrants exercisable, description
Warrants term
Warrants and Rights Outstanding, Measurement Input
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Shares Common stock options, outstanding at beginning balance
Number of Shares, Granted
Weighted Average Exercise Price, Granted
Weighted Average Remaining Contractual Term, Grants
Number of Shares, Exercised
Number of Shares, Forfeitures or expirations
Weighted Average Exercise Price, Forfeitures and expirations
Weighted Average Exercise Price, Outstanding Beginning Balance
Weighted Average Remaining Contractual Life (Years) Outstanding
Number of Shares Common stock options, outstanding at ending balance
Weighted Average Exercise Price, Outstanding Ending Balance
Shares, Vested and expected to vest
Shares, Exercisable
Risk-free interest rate
Expected term (in years)
Expected volatility
Expected dividend yield
Common stock available for future issuance
Share based compensation arrangement by share based payment award, description
Share based compensation
Unrecognized share based costs
Grant date fair value
Aggregate intrinsic value
Federal income tax benefit at statutory rate
State income tax benefit
Permanent differences
Change in valuation allowance
Research and development tax credit- prior period
Other
Total income tax expense
Research and development costs
Other
Net operating losses
Research and development costs
Unvested stock options
Research and development tax credits
Patents
Right-of-use assets
Gross deferred income tax assets
Less: valuation allowance
Net deferred income tax asset
Property and equipment
Gross deferred income tax liabilities
Net deferred tax asset (liability)
Net deferred tax assets
Summary Of Components Of Lease Cost
Operating lease cost
Amortization of right-of-use assets
Interest on lease liabilities
Total finance lease cost
Total lease cost
Summary Of Lease Reported In Consolidated Balance Sheets
Operating lease liabilities, net of current
Total operating lease liabilities
Property and equipment
Accumulated amortization
Property and equipment, net
Total finance lease liabilities
Reductions to ROU assets resulting from reductions to lease obligations: Operating leases
Reductions to ROU assets resulting from reductions to lease obligations: Finance leases
Weighted average remaining lease term: Operating leases
Weighted average remaining lease term: Finance leases
Weighted average discount rate: operating leases
Weighted average discount rate: Finance leases
Lessee, Lease, Description [Table]
Lessee, Lease, Description [Line Items]
2025
Thereafter
Total undiscounted lease payments
Less imputed interest
Total lease liabilities
Lease term
Rent expense per month
Lease incentive by lessor of tenant improvements
Lease description
Percentage of imputed interest rate, lease obligation
Antidilutive Security, Excluded EPS Calculation [Table]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities
Intangible Asset, Indefinite-Lived [Table]
Indefinite-Lived Intangible Assets [Line Items]
Milestone payment
Related Party Transaction [Table]
Related Party Transaction [Line Items]
Rental expense
Principal amount
Subsequent Event [Table]
Subsequent Event [Line Items]
Sale of stock, number of shares issued in transaction
Sale Of Common Stock [Text Block]
Series A and Series B Warrants [Member]
Class of warrant or right fair value per warrants.
Gross proceeds.
WFIA Pre Funded Warrants [Member]
Werth Family Investment Associates LLC [Member]
June 2024 Warrant Inducement [Member]
February 2024 Warrants [Member]
Stock issued during period value issuance of common stock in connection with private placement with wfia.
Series D Common Stock [Member
Stock issued during period value issuance of common stock in connection with private placement with wfia, shares.
Purchase Agreement [Member]
Stock issued during period value reverse stock splits.
Stock Issued Value Warrant Inducement.
Stock Issued Shares Warrant Inducement.
ATM Agreement [Member]
H.C. Wain Wright and Co LLC [Member]
Share issuance value.
Series A Warrants [Member]
Series B Warrants [Member]
Common Stock Purchase Warrants [Text Block]
Stock issued during period value conversion of convertible securities related party note payable.
Series A Warrant [Member]
Series B Warrant [Member]
Operating lease right-of-use assets.
Increase decrease in long-term portion of operating lease liability.
Placement Agent Warrants [Member]
Schedule Of Fair Value Of Warrants To Additional Paid In Capital [Table Text Block]
Series A, B Placement Agent Warrants [Member]
Equity fair value percentage.
Amount allocated.
Common Stock Purchase Warrants [Policy Text Block]
September Two Thousand Twenty Three Public Offering [Member]
February Two Thousand Twenty Four Public Offering [Member]
Series C And Series D Warrants [Member]
Clinical Operations [Member]
December 2021 Initial Public Offering Warrants [Member]
Drug Manufacturing [Member]
Personnel [Member]
December 2021 Placement Agent Warrants [Member]
December Two Thousand TwentyOne Underwriter Warrants [Member]
September 2023 Public Offering Series A Warrants [Member]
Legal And Professional Fees [Member]
September 2023 Public Offering Series B Warrants [Member]
Insurance [Member]
September 2023 Placement Agent Warrants [Member]
Other [Member]
February 2024 Public Offering Series A Warrants [Member]
February 2024 Public Offering Series B Warrants [Member]
February 2024 Placement Agent Warrants [Member]
June Two Thousand Twenty Four Series C Warrants [Member]
June 2024- Series D Warrants [Member]
July 2024 Placement Agent Warrants [Member]
2021 Equity Incentive Plan [Member]
2021 [Equity Incentive Plan Plan Member]
Prepaid Expenses and Other Current Assets [TextBlock]
Prepaid research and development.
Prepaid active pharmaceutical ingredients.
Prepaid dues and subscriptions.
Accrued research and development costs current.
Related Party Note Payble [Disclosure Text Block]
Warrants or rights immediately exercisable per shares price.
Share based compensation arrangement by share based payment award options grant weighted average remaining contractual term 2.
Streetville Capital LLC [Member]
Employees And Directors [Member]
Income tax reconciliation permanent difference.
Income tax reconciliation research and development tax crediit prior period.
Deferred tax assets in research and development costs current.
Deferred tax assets other current.
Deferred tax assets unvested stock options non current.
Deferred tax assets in research and development tax credit.
Deferred tax assets right of use assets.
Kansas City Office [Member]
Office Facilities Space [Member]
Percentage of imputed interest rate of lease obligation.
Finance lease cost.
Schedule Of Lease Assets And Liabilities Recorded In Consolidated Balance Sheets [Table Text Block]
Operating leases reductions to right of use assets lease obligations.
Finance leases reductions to right of use assets lease obligations.
Schedule Of Operating And Finance Lease Liability Maturity [Table Text Block]
Operating Lease [Member].
WFIA [Member]
Streeterville Capital [Member]
Milestone payment.
Phase 3 Clinical Trial [Member]
New Drug Application [Member].
CTx-1301 and CTx-1302 [Member]
CTx-2103 [Member]
CTx-2103 [Member]
Long term debt outstanding including accrued interest.
Debt instrument original discount.
Lender expenses on issue of debt.
Default long term debt description of event of default.
Issuance of common stock and pre-funded warrants sold for cash in public offering, net of fees, values
Issuance of common stock and pre-funded warrants sold for cash in public offering, net of fees, shares
CTx-2103 [Member] [Default Label]
Assets, Current
Assets
Liabilities, Current
Liabilities, Noncurrent
Liabilities
Equity, Attributable to Parent
Liabilities and Equity
Operating Income (Loss)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Shares, Outstanding
Increase (Decrease) in Accounts and Notes Receivable
Increase (Decrease) in Prepaid Expense and Other Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
Net Cash Provided by (Used in) Operating Activities
Payments to Acquire Property, Plant, and Equipment
Net Cash Provided by (Used in) Investing Activities
Finance Lease, Principal Payments
Net Cash Provided by (Used in) Financing Activities
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
RelatedPartyNotePaybleDisclosureTextBlock
Equity [Text Block]
Sale Of Common Stock [Text Block]
Common Stock Purchase Warrants [Text Block]
Lessee, Operating Leases [Text Block]
Property, Plant and Equipment, Policy [Policy Text Block]
Lessee, Leases [Policy Text Block]
Compensation Related Costs, Policy [Policy Text Block]
Income Tax, Policy [Policy Text Block]
Common Stock Purchase Warrants [Policy Text Block]
PrepaidResearchAndDevelopment
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
AccruedResearchAndDevelopmentCostsCurrent
Other Accrued Liabilities, Current
Accrued Insurance, Current
Other Nonoperating Income
DefaultLongtermDebtDescriptionOfEventOfDefault
GrossProceeds
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
DeferredTaxAssetsOtherCurrent
Deferred Tax Asset, In-Process Research and Development
Deferred Tax Assets, Gross
Deferred Tax Assets, Valuation Allowance
Deferred Tax Assets, Net of Valuation Allowance
Deferred Tax Liabilities, Property, Plant and Equipment
Deferred Tax Liabilities, Gross
Deferred Tax Assets, Net
FinanceLeaseCost
Lease, Cost
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization
Finance Lease, Liability
Lessee, Operating Lease, Liability, to be Paid
Lessee, Operating Lease, Liability, Undiscounted Excess Amount